Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | MDH1 | P40925 | 1/20 | 0.33 |
| ▸ | MDH2 | P40926 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | USP2 | O75604 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.32 |
| ▸ | ESR1 | P03372 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL28414616 | 0.96 | SHBG (0.52) | SHBGCYP3A4SMN1; SMN2HIF1ACYP2D6 | |
| SCHEMBL8371758 | 0.89 | SHBG (0.45) | SHBGCYP3A4SMN1; SMN2TAAR1 | |
| SCHEMBL15266429 | 0.80 | SHBG (0.36) | SHBGCYP3A4SMN1; SMN2TAAR1MAPT | |
| SCHEMBL578291 | 0.78 | NPC1 (0.44) | SMN1; SMN2LMNATAAR1MAPTMAPK1 | |
| Water SCHEMBL28217447 | 0.78 | SHBG (0.58) | SHBGCYP3A4SMN1; SMN2HIF1ACYP2D6 | |
| SCHEMBL10650836 | 0.77 | CYP3A4 (0.54) | SHBGCYP3A4SMN1; SMN2HIF1ACYP2D6 | |
| SCHEMBL21684968 | 0.76 | TAAR1 (0.33) | SHBGTAAR1ESR1ESR2 | |
| SCHEMBL1032610 | 0.76 | TAAR1 (0.33) | SHBGTAAR1ESR1ESR2 | |
| SCHEMBL16035570 | 0.76 | TAAR1 (0.33) | SHBGTAAR1ESR1ESR2 | |
| SCHEMBL317457 | 0.76 | CNR1 (0.38) | SHBGCYP3A4SMN1; SMN2TAAR1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113493870-B | Composite flocculant for ion type rare earth enrichment and enrichment method | 福建省长汀金龙稀土有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-112830989-B | Long-chain branched ethylene propylene rubber and preparation method thereof | 北京引发科技有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-113493870-A | Composite flocculant for ion type rare earth enrichment and enrichment method | 厦门钨业股份有限公司 | 2021-10-12 | — | — | CN | claimed |
| CN-112830989-A | Long-chain branched ethylene propylene rubber and preparation method thereof | 北京引发科技有限公司 | 2021-05-25 | — | — | CN | claimed |
| US-20200276315-A1 | POVIDONE-IODINE TOPICAL COMPOSITION | JAMES D HOSLER (US) | 2020-09-03 | — | — | US | claimed |
| EP-2838977-B1 | A METHOD TO TREAT FLUSHING LIQUOR SYSTEMS IN COKE PLANTS | BL TECHNOLOGIES INC (US) | 2019-10-02 | — | — | EP | claimed |
| EP-3095469-B1 | PROCESS FOR BONE TISSUE DECELLULARIZATION | INCI ILYAS (US) | 2019-09-11 | — | — | EP | claimed |
| CN-110041732-A | Leather acid blue dyestuff and preparation method thereof | 天津市宏津盛化工有限公司 | 2019-07-23 | — | — | CN | claimed |
| EP-2773201-B1 | IMPROVED COMPOSITIONS COMPRISING POVIDONE-IODINE COMPLEX | MICRODERMIS CORP (US) | 2017-12-06 | — | — | EP | claimed |
| CN-107419098-A | A kind of method of extracting rare-earth in sulphuric leachate from Ree-phospeate Minerals | 广东省稀有金属研究所 | 2017-12-01 | — | — | CN | claimed |
| US-4460602-A | ANALGESICS, ANTIINFLAMMATORY AGENTS, DEPILATORIES | THE PROCTER & GAMBLE COMPANY (US) | 1984-07-17 | — | — | US | claimed |
| EP-0021626-B1 | SALTS OF PHOSPHORIC ACID DIESTERS, THEIR PREPARATION AND USE IN MEMBRANES, THE MEMBRANES AND THEIR USE IN CALCIUM ION DETERMINATION, AND THE ELECTRODES CONTAINING THEM | BECKMAN INSTRUMENTS, INC. (US) | 1984-01-18 | — | — | EP | claimed |
| US-4369317-A | CALCIUM ION SELECTIVE MEMBRANE | BECKMAN INSTRUMENTS, INC. (US) | 1983-01-18 | — | — | US | claimed |
| US-4338440-A | CALCIUM ION SELECTIVE MEMBRANE COMPONENT | BECKMAN INSTRUMENTS, INC. (US) | 1982-07-06 | — | — | US | claimed |
| US-4271002-A | Calcium ion-selective electrodes and membrane for use therein | BECKMAN INSTRUMENTS, INC. (US) | 1981-06-02 | — | — | US | claimed |
| EP-0021626-A1 | Salts of phosphoric acid diesters, their preparation and use in membranes, the membranes and their use in calcium ion determination, and the electrodes containing them | BECKMAN INSTRUMENTS, INC. (US) | 1981-01-07 | — | — | EP | claimed |
| US-4211867-A | ANTISECRETORY AGENTS, HYPOGLYCEMIC AGENTS, ANTIARRHYTHMIA AGENTS | MCNEIL LABORATORIES, INCORPORATED (US) | 1980-07-08 | — | — | US | claimed |
| US-4093587-A | Trisubstituted hydroxyphenylalkanoic acid ester and amide stabilized compositions | CIBA-GEIGY CORPORATION (US) | 1978-06-06 | — | — | US | claimed |
| US-3997597-A | ANTIOXIDANTS FOR LUBRICANTS AND GREASES | MOBIL OIL CORPORATION (US) | 1976-12-14 | — | — | US | claimed |
| US-3984460-A | LIGHT AND HEAT STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1976-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200276315-A1 | POVIDONE-IODINE TOPICAL COMPOSITION | CUTA, POLR1C, POLI | SHBG 3370/4885CYP3A4 2060/4885SMN1; SMN2 3115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.